STOCK TITAN

Rhea Posedel sells AEHR shares (Nasdaq: AEHR) across April 2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AEHR insider Rhea Posedel reported multiple sales of common stock in April 2026 as disclosed on a Form 144. The filing lists individual trades including 30,000 shares on 04/09/2026 for $2,100,000 and other April trades with proceeds shown for each date. The filing also shows previously issued shares from compensation (604 shares, 10/20/2020) and an ESOP award (17,115 shares, 06/02/2025).

Positive

  • None.

Negative

  • None.
Sale on 04/09/2026 30,000 shares proceeds $2,100,000
Sale on 04/16/2026 15,000 shares proceeds $1,210,800.00
Sale on 04/17/2026 7,500 shares proceeds $615,000.00
Sale on 04/20/2026 7,500 shares proceeds $660,675.00
Sale on 04/21/2026 8,787 shares proceeds $843,756.73
Compensation issuance 604 shares dated 10/20/2020
ESOP award 17,115 shares dated 06/02/2025
Form 144 regulatory
"reported multiple sales of common stock in April 2026"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
ESOP financial
"ESOP | Issuer | 17115 | 06/02/2025"
An Employee Stock Ownership Plan (ESOP) is a program that gives employees ownership shares in their company, often as part of their benefits package. It acts like a company-sponsored savings plan, allowing workers to have a stake in the company's success, which can boost motivation and loyalty. For investors, ESOPs can influence company decisions and stock value, making them an important aspect of corporate ownership and governance.
Compensation financial
"common | 10/20/2020 | Compensation | Issuer | 604"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares did AEHR insider Rhea Posedel sell in April 2026?

Rhea Posedel sold multiple common-stock blocks between 04/09/2026 and 04/21/2026. The filing lists trades including 30,000 shares on 04/09/2026 for $2,100,000 and additional sales on 04/16–04/21 with share counts and proceeds for each trade.

Which dates and amounts are shown for Rhea Posedel's sales in the Form 144?

Trades are dated 04/09/2026, 04/16/2026, 04/17/2026, 04/20/2026 and 04/21/2026. Each line in the filing shows the share count and proceeds, for example 30,000 shares for $2,100,000 on 04/09/2026.

Does the filing show the source of the shares sold by the AEHR insider?

Yes; the filing lists share sources including Compensation (604 shares, dated 10/20/2020) and an ESOP award (17,115 shares, dated 06/02/2025). The sales reported in April 2026 reference common stock disposals.

Which broker or market is listed for these AEHR transactions?

The excerpt lists Oppenheimer & Co, Inc with an address and notes the market as Nasdaq. Specific execution methods are not detailed beyond broker and market references in the filing.

Are proceeds shown for each sale in the AEHR Form 144?

Yes; each sale line includes proceeds. Examples: 30,000 shares on 04/09/2026 for $2,100,000; 8,787 shares on 04/21/2026 for $843,756.73. Each trade entry pairs share counts with dollar proceeds.